Gongora, C. A. Et Al. 2022. Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines. JACC: Heart Failure , vol.10, no.8 , 559-567.

Gongora, C. A., Drobni, Z. D., Quinaglia Araujo Costa Silva, T., Zafar, A., Gong, J., Zlotoff, D. A., ... Gilman, H. K.(2022). Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines. JACC: Heart Failure , vol.10, no.8, 559-567.

Gongora, Carlos Et Al. "Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines," JACC: Heart Failure , vol.10, no.8, 559-567, 2022

Gongora, Carlos A. Et Al. "Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines." JACC: Heart Failure , vol.10, no.8, pp.559-567, 2022

Gongora, C. A. Et Al. (2022) . "Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines." JACC: Heart Failure , vol.10, no.8, pp.559-567.

@article{article, author={Carlos A. Gongora Et Al. }, title={Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines}, journal={JACC: Heart Failure}, year=2022, pages={559-567} }